Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) was the target of a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 172,947 shares, a growth of 19.9% from the January 15th total of 144,184 shares. Based on an average daily trading volume, of 68,792 shares, the days-to-cover ratio is currently 2.5 days. Based on an average daily trading volume, of 68,792 shares, the days-to-cover ratio is currently 2.5 days.
Neonc Technologies Stock Performance
Shares of NASDAQ NTHI traded down $0.98 during mid-day trading on Tuesday, reaching $9.26. 52,580 shares of the company were exchanged, compared to its average volume of 67,664. Neonc Technologies has a twelve month low of $3.20 and a twelve month high of $25.00. The company’s 50-day simple moving average is $9.09 and its 200-day simple moving average is $8.84.
Neonc Technologies (NASDAQ:NTHI – Get Free Report) last issued its quarterly earnings results on Friday, November 14th. The company reported ($0.45) earnings per share (EPS) for the quarter.
Analyst Ratings Changes
Read Our Latest Stock Analysis on NTHI
Insider Buying and Selling at Neonc Technologies
In other Neonc Technologies news, President Amir F. Heshmatpour purchased 24,000 shares of Neonc Technologies stock in a transaction on Friday, November 21st. The shares were purchased at an average cost of $6.07 per share, with a total value of $145,680.00. Following the completion of the transaction, the president directly owned 2,986,000 shares in the company, valued at approximately $18,125,020. This represents a 0.81% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Over the last quarter, insiders bought 31,100 shares of company stock valued at $192,099.
Institutional Inflows and Outflows
A number of hedge funds have recently made changes to their positions in the business. HighPoint Advisor Group LLC increased its holdings in shares of Neonc Technologies by 424.8% during the third quarter. HighPoint Advisor Group LLC now owns 950,232 shares of the company’s stock valued at $8,628,000 after acquiring an additional 769,163 shares in the last quarter. Bank of America Corp DE purchased a new position in Neonc Technologies in the second quarter worth about $801,000. Vanguard Group Inc. bought a new stake in shares of Neonc Technologies during the 3rd quarter worth approximately $1,279,000. Global Retirement Partners LLC purchased a new stake in Neonc Technologies in the third quarter worth about $434,000. Finally, Royal Bank of Canada purchased a new position in shares of Neonc Technologies in the 1st quarter worth approximately $247,000.
About Neonc Technologies
Neonc Technologies Holdings, Inc develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.
Featured Stories
- Five stocks we like better than Neonc Technologies
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
